 SAN DIEGO, CA ACCESSWIRE August 24, 2022 Ensysce Biosciences, Inc. Ensysce or the Company NASDAQ:ENSC OTC:ENSCW, a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety to reduce abuse and overdose, today announced its participation in the following upcoming conferences: PAINWeek Conference 2022, September 6 - September 9, 2022, in Las Vegas, NV. Dr. Lynn Kirkpatrick, Chief Executive Officer, to chair a symposium and panel, entitled, Severe Pain, Strategic Perspectives. 